The effects of cholinomimetic drugs and atropine on ACTH release

G. Makara, E. Stark

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Acetylcholine (1 and 50 μg), carbamylcholine (1 and 10 μg), and oxotremorine (10 μg) were infused into the 3rd ventricle of rats with deafferented medial basal hypothalamus (MBH); infusions failed to stimulate ACTH release as shown by the plasma corticosterone level. Implants of an atropine fluorescein mixture (200-250 μg) inhibited the stress induced rise of plasma corticosterone only when dye from the implant stained large portions of the median eminence and the basal hypothalamus. Atropine implants near the electrodes inhibited the rise in plasma corticosterone usually produced by electrical stimulation in the anterior hypothalamus. Atropine crystals or a 2% atropine sulphate solution placed on the median eminence blocked conduction of action potential in the hypothalamoneurohypophyseal and tubero infundibular pathways. The evidence is discussed for and against the participation of a cholinergic synapse (in the MBH) that activates ACTH release after stressful neural stimuli.

Original languageEnglish
Pages (from-to)31-41
Number of pages11
JournalNeuroendocrinology
Volume21
Issue number1
Publication statusPublished - 1976

Fingerprint

Atropine
Adrenocorticotropic Hormone
Cholinergic Agents
Corticosterone
Middle Hypothalamus
Median Eminence
Pharmaceutical Preparations
Oxotremorine
Anterior Hypothalamus
Third Ventricle
Carbachol
Fluorescein
Synapses
Electric Stimulation
Hypothalamus
Action Potentials
Acetylcholine
Electrodes
Coloring Agents

ASJC Scopus subject areas

  • Endocrinology
  • Neuroscience(all)

Cite this

The effects of cholinomimetic drugs and atropine on ACTH release. / Makara, G.; Stark, E.

In: Neuroendocrinology, Vol. 21, No. 1, 1976, p. 31-41.

Research output: Contribution to journalArticle

@article{7b0f170c5376461bb6dbc58ede4a4e2e,
title = "The effects of cholinomimetic drugs and atropine on ACTH release",
abstract = "Acetylcholine (1 and 50 μg), carbamylcholine (1 and 10 μg), and oxotremorine (10 μg) were infused into the 3rd ventricle of rats with deafferented medial basal hypothalamus (MBH); infusions failed to stimulate ACTH release as shown by the plasma corticosterone level. Implants of an atropine fluorescein mixture (200-250 μg) inhibited the stress induced rise of plasma corticosterone only when dye from the implant stained large portions of the median eminence and the basal hypothalamus. Atropine implants near the electrodes inhibited the rise in plasma corticosterone usually produced by electrical stimulation in the anterior hypothalamus. Atropine crystals or a 2{\%} atropine sulphate solution placed on the median eminence blocked conduction of action potential in the hypothalamoneurohypophyseal and tubero infundibular pathways. The evidence is discussed for and against the participation of a cholinergic synapse (in the MBH) that activates ACTH release after stressful neural stimuli.",
author = "G. Makara and E. Stark",
year = "1976",
language = "English",
volume = "21",
pages = "31--41",
journal = "Neuroendocrinology",
issn = "0028-3835",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - The effects of cholinomimetic drugs and atropine on ACTH release

AU - Makara, G.

AU - Stark, E.

PY - 1976

Y1 - 1976

N2 - Acetylcholine (1 and 50 μg), carbamylcholine (1 and 10 μg), and oxotremorine (10 μg) were infused into the 3rd ventricle of rats with deafferented medial basal hypothalamus (MBH); infusions failed to stimulate ACTH release as shown by the plasma corticosterone level. Implants of an atropine fluorescein mixture (200-250 μg) inhibited the stress induced rise of plasma corticosterone only when dye from the implant stained large portions of the median eminence and the basal hypothalamus. Atropine implants near the electrodes inhibited the rise in plasma corticosterone usually produced by electrical stimulation in the anterior hypothalamus. Atropine crystals or a 2% atropine sulphate solution placed on the median eminence blocked conduction of action potential in the hypothalamoneurohypophyseal and tubero infundibular pathways. The evidence is discussed for and against the participation of a cholinergic synapse (in the MBH) that activates ACTH release after stressful neural stimuli.

AB - Acetylcholine (1 and 50 μg), carbamylcholine (1 and 10 μg), and oxotremorine (10 μg) were infused into the 3rd ventricle of rats with deafferented medial basal hypothalamus (MBH); infusions failed to stimulate ACTH release as shown by the plasma corticosterone level. Implants of an atropine fluorescein mixture (200-250 μg) inhibited the stress induced rise of plasma corticosterone only when dye from the implant stained large portions of the median eminence and the basal hypothalamus. Atropine implants near the electrodes inhibited the rise in plasma corticosterone usually produced by electrical stimulation in the anterior hypothalamus. Atropine crystals or a 2% atropine sulphate solution placed on the median eminence blocked conduction of action potential in the hypothalamoneurohypophyseal and tubero infundibular pathways. The evidence is discussed for and against the participation of a cholinergic synapse (in the MBH) that activates ACTH release after stressful neural stimuli.

UR - http://www.scopus.com/inward/record.url?scp=0017141435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017141435&partnerID=8YFLogxK

M3 - Article

C2 - 187978

AN - SCOPUS:0017141435

VL - 21

SP - 31

EP - 41

JO - Neuroendocrinology

JF - Neuroendocrinology

SN - 0028-3835

IS - 1

ER -